EA200200635A1 - FLUORESCENT CONTRAST AGENT FOR NEAR INFRARED SPECTRUM AND METHOD OF FLUORESCENT VISUALIZATION - Google Patents

FLUORESCENT CONTRAST AGENT FOR NEAR INFRARED SPECTRUM AND METHOD OF FLUORESCENT VISUALIZATION

Info

Publication number
EA200200635A1
EA200200635A1 EA200200635A EA200200635A EA200200635A1 EA 200200635 A1 EA200200635 A1 EA 200200635A1 EA 200200635 A EA200200635 A EA 200200635A EA 200200635 A EA200200635 A EA 200200635A EA 200200635 A1 EA200200635 A1 EA 200200635A1
Authority
EA
Eurasian Patent Office
Prior art keywords
contrast agent
near infrared
spectrum
fluorescent
infrared region
Prior art date
Application number
EA200200635A
Other languages
Russian (ru)
Inventor
Наота Мива
Мичихито Инагаки
Хироаки Эгучи
Масафуми Окумура
Ёшио Инагаки
Тору Харада
Original Assignee
Шеринг Акциенгезельшафт
Фуджи Фото Филм Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Акциенгезельшафт, Фуджи Фото Филм Ко., Лтд. filed Critical Шеринг Акциенгезельшафт
Publication of EA200200635A1 publication Critical patent/EA200200635A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032Methine dyes, e.g. cyanine dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)

Abstract

В заявке описан флуоресцентный контрастный агент для ближней инфракрасной области спектра, содержащий соединение, имеющее в молекуле три или более групп сульфоновой кислоты, и способ флуоресцентной визуализации, предусматривающий введение флуоресцентного контрастного агента для ближней инфракрасной области спектра по настоящему изобретению в живой организм, облучение организма возбуждающим светом и обнаружение флуоресценции в ближней инфракрасной области спектра, испускаемой контрастным агентом. Флуоресцентный контрастный агент для ближней инфракрасной области спектра по настоящему изобретению облучают возбуждающим светом и он испускает флуоресценцию в ближней инфракрасной области спектра. Эта инфракрасная флуоресценция хорошо проходит через биологические ткани. Вследствие этого оказывается возможным обнаруживать повреждения в глубоко расположенных областях живого организма. Кроме того, контрастный агент по изобретению обладает хорошей растворимостью в воде и является малотоксичным и следовательно безопасным для применения.Международная заявка была опубликована вместе с отчетом о международном поиске.The application describes a fluorescent contrast agent for the near infrared region of the spectrum, containing a compound that has three or more sulfonic acid groups in a molecule, and a fluorescence imaging method that involves introducing the fluorescent contrast agent for the near infrared spectrum of the present invention into a living organism, irradiating the body with an exciting light and fluorescence detection in the near infrared region of the spectrum emitted by a contrast agent. The fluorescent contrast agent for the near infrared region of the spectrum of the present invention is irradiated with excitation light and it emits fluorescence in the near infrared region of the spectrum. This infrared fluorescence passes well through biological tissue. As a result, it is possible to detect lesions in deep areas of a living organism. In addition, the contrast agent of the invention has good solubility in water and is of low toxicity and therefore safe to use. The international application was published together with an international search report.

EA200200635A 1999-12-15 1999-12-15 FLUORESCENT CONTRAST AGENT FOR NEAR INFRARED SPECTRUM AND METHOD OF FLUORESCENT VISUALIZATION EA200200635A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/009959 WO2001043781A1 (en) 1999-12-15 1999-12-15 Near infrared fluorescent contrast agent and fluorescence imaging

Publications (1)

Publication Number Publication Date
EA200200635A1 true EA200200635A1 (en) 2002-12-26

Family

ID=8167530

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200635A EA200200635A1 (en) 1999-12-15 1999-12-15 FLUORESCENT CONTRAST AGENT FOR NEAR INFRARED SPECTRUM AND METHOD OF FLUORESCENT VISUALIZATION

Country Status (19)

Country Link
EP (1) EP1237583A1 (en)
JP (1) JP2003517025A (en)
KR (1) KR20020082207A (en)
CN (1) CN1217701C (en)
AU (1) AU2097500A (en)
BG (1) BG106822A (en)
BR (1) BR9917587A (en)
CA (1) CA2394539C (en)
EA (1) EA200200635A1 (en)
EE (1) EE200200321A (en)
HU (1) HUP0204024A2 (en)
IL (1) IL149798A0 (en)
MX (1) MXPA02005806A (en)
NO (1) NO328630B1 (en)
PL (1) PL355891A1 (en)
SK (1) SK8142002A3 (en)
TR (1) TR200201567T2 (en)
WO (1) WO2001043781A1 (en)
YU (1) YU44402A (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682602B2 (en) * 2003-12-19 2010-03-23 Konica Minolta Medical & Graphic, Inc. Near-infrared fluorescent contrast medium
JP2005220045A (en) * 2004-02-04 2005-08-18 Konica Minolta Medical & Graphic Inc Fluorescent contrast agent
JP5074044B2 (en) * 2007-01-18 2012-11-14 オリンパス株式会社 Fluorescence observation apparatus and method of operating fluorescence observation apparatus
WO2009023813A1 (en) * 2007-08-15 2009-02-19 Applied Soil Water Technologies Llc Metals recovery from mining heap leach ore
US20090214436A1 (en) 2008-02-18 2009-08-27 Washington University Dichromic fluorescent compounds
CA2809798C (en) 2009-08-28 2018-09-18 Visen Medical, Inc. Systems and methods for tomographic imaging in diffuse media using a hybrid inversion technique
JP2011046663A (en) 2009-08-28 2011-03-10 Fujifilm Corp Near infrared fluorescent imaging agent
CN102781307B (en) 2009-09-22 2016-01-20 文森医学公司 For the system and method for the virtual refractive index match of diffusive medium
US20130158394A1 (en) * 2010-01-14 2013-06-20 The Regents Of The University Of California Devices, Systems and Methods to Detect and Reduce or Prevent Entry of Inflammatory Mediators into Milk Ducts
GB201010878D0 (en) 2010-06-29 2010-08-11 Ge Healthcare As Dye compositiion and dye syntheses
EP2806781B1 (en) 2012-01-23 2018-03-21 Washington University Goggle imaging systems and methods
US10743768B2 (en) 2012-10-15 2020-08-18 Visen Medical, Inc. Systems, methods, and apparatus for imaging of diffuse media featuring cross-modality weighting of fluorescent and bioluminescent sources
MX358184B (en) 2013-03-15 2018-08-08 Purdue Research Foundation Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors.
AU2014373656B2 (en) 2013-12-31 2019-12-05 Cornell University Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time
ES2794778T3 (en) 2014-12-15 2020-11-19 Memorial Sloan Kettering Cancer Center Cyclic peptides with improved selectivity of nerve binding, nanoparticles bound with said cyclic peptides and use of the same for live imaging of nerve tissues in real time
US10806804B2 (en) 2015-05-06 2020-10-20 Washington University Compounds having RD targeting motifs and methods of use thereof
DK3166606T3 (en) 2015-06-03 2018-08-13 Surgimab S A S FLUORESCING CONJUGATES
CN105222828B (en) * 2015-09-30 2017-05-24 东南大学 Synchronization measurement device for wall-adherent jet speed field and concentration field and method
EP3389726A1 (en) 2015-12-15 2018-10-24 Memorial Sloan Kettering Cancer Center Imaging systems and methods for tissue differentiation, e.g., for intraoperative visualization
CN110167601A (en) 2016-11-30 2019-08-23 纪念斯隆凯特琳癌症中心 Inhibitor-small nanoparticle of functionalization ultra micro and its method
CN111970960A (en) 2018-03-30 2020-11-20 珀金埃尔默健康科学有限公司 System and method for 3D reconstruction of anatomical organs and contents using Short Wave Infrared (SWIR) projection tomography
WO2021119423A1 (en) 2019-12-13 2021-06-17 Washington University Near infrared fluorescent dyes, formulations and related methods
EP4015004A1 (en) 2020-12-18 2022-06-22 Phi Pharma SA Proteoglycan specific branched peptides
CN114459862A (en) * 2022-01-13 2022-05-10 华腾实业(深圳)股份有限公司 High-identification fungus fluorescent staining solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3224538B2 (en) * 1990-05-15 2001-10-29 ダイアトロン・コーポレイション Fluorescent porphyrin as fluorescent probe and fluorescent phthalocyanine-polyethylene glycol, polyol and saccharide derivative
CA2211470A1 (en) * 1995-01-30 1996-08-08 Daiichi Pure Chemicals Co., Ltd. Diagnostic marker
JP2000095758A (en) * 1998-09-18 2000-04-04 Schering Ag Near-infrared, fluorescent contrast medium, and its production

Also Published As

Publication number Publication date
HUP0204024A2 (en) 2003-04-28
PL355891A1 (en) 2004-05-31
BG106822A (en) 2003-01-31
CA2394539A1 (en) 2001-06-21
CN1384760A (en) 2002-12-11
WO2001043781A1 (en) 2001-06-21
NO20022837L (en) 2002-06-14
EP1237583A1 (en) 2002-09-11
SK8142002A3 (en) 2002-12-03
CA2394539C (en) 2009-10-27
YU44402A (en) 2005-03-15
BR9917587A (en) 2002-08-06
NO20022837D0 (en) 2002-06-14
KR20020082207A (en) 2002-10-30
EE200200321A (en) 2003-10-15
MXPA02005806A (en) 2010-10-26
CN1217701C (en) 2005-09-07
JP2003517025A (en) 2003-05-20
TR200201567T2 (en) 2002-11-21
IL149798A0 (en) 2002-11-10
NO328630B1 (en) 2010-04-12
AU2097500A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
EA200100318A1 (en) FLUORESCENT CONTRAST AGENT FOR NEAR INFRARED SPECTRUM AND METHOD OF FLUORESCENT VISUALIZATION
EA200200635A1 (en) FLUORESCENT CONTRAST AGENT FOR NEAR INFRARED SPECTRUM AND METHOD OF FLUORESCENT VISUALIZATION
US5474910A (en) Method and device for detecting biological molecules and/or microorganisms within a desired area or space
AU2010244431B2 (en) A system, method, and luminescent marker for improved diffuse luminescent imaging or tomography in scattering media
KR20190122890A (en) Imaging a target fluorophore in a biological material in the presence of autofluorescence
ATE360392T1 (en) IN VIVO MULTIPHOTON DIAGNOSTIC DETECTION AND IMAGING OF A NEURODEGENERATIVE DISEASE
DE60109740D1 (en) METHOD FOR AVOIDING FLUORESCENCE DELETION
JP2011115658A (en) Optical imaging of induced signal in vivo under ambient light condition
ATE291879T1 (en) METHOD FOR AVOIDING FLUORESCENCE QUENCHMENT
Natarajan et al. A far-red to NIR emitting ultra-sensitive probe for the detection of endogenous HOCl in zebrafish and the RAW 264.7 cell line
Urayama et al. Fluorescence lifetime imaging microscopy of endogenous biological fluorescence
Ji et al. NIR-II fluorescence imaging without intended excitation light
US11871988B1 (en) Mapping and endoscopic excision of a tumor using intracavity laser quenching and emission spectroscopy
JP7297912B2 (en) Halitosis improver or halitosis preventive
TR200202652T2 (en) Infrared fluorescent contrast agent and fluorescence image
Jabarah et al. Lumonil Compounds in Criminal Chemistry (A Review)
JP2006284298A (en) Diagnostic method of tumor of colon
Wu et al. THE NEAR-LNFRARED-II FLUORESCENCE IMAGING PROBES FOR SURGICAL NAVIGATION
Da FCLA assisted Photo-Dynamic Diagnosis
Russell A non-invasive technique for in vivo pharmacokinetic measurements using optical fiber spectrofluorimetry
Wang et al. Experimental research of photodynamic diagnosis mediated by chemiluminescence reagents